Roadmap

SpaceJX Roadmap

Market Sector Research.
Market Analysis.
Incorporation Planning.
Strategic Planning.

Pre-Phase 0 - 2023-2024 | Market research

Expansion of R&D teams in biotechnology and aerospace.
Partnerships with universities and research centers.
Development of functional prototypes in photonics and applied biotechnology.
Research in advanced aerospace materials and particle study.
Global investor platform improvement (with reporting and metrics)
Series A fundraising (conversion of SAFEs).

Phase 2 – 2026–2028 | Expansion & Prototyping

Legal incorporation in the U.S. (C-Corp).Launch of the investment platform (SAFE, Reg CF, Reg D).
Initial fundraising via angel investors & crowdfunding.
Beginning of research in genetic engineering without clinical application, research on synthetic proteins.
Prototyping of photonic and organic processor concepts (light processors and organic processors).
Launch of global investor platform.

Phase 1 – 2025–2026 | Foundation & Early Research

Advanced testing of technologies in controlled environments.
Initial regulatory certifications (where applicable).
Creation of spin-offs for commercially viable technologies.
Expansion into aerospace programs (collaborations with agencies and private partners).
Series B fundraising / potential IPO.
Consolidation of SpaceJX as a global deep-tech leader.

Phase 3 – 2028–2032 | Scaling & Commercialization

Everything that can be done must be done!

We must strive as a species to ensure that, through the necessary means, our descendants can explore space and have at their disposal tools and technologies that enable the maintenance of the species in any environment that is necessary and possible, through clear and defined scientific means and methods.

SpaceJX is the union of human will, representing the determination and sacrifice of our ancestors and our descendants in a single common goal, the perpetuation and continuity of our species.

Important: This website is for informational purposes only and does not constitute an offer to buy or sell securities. Any offer will be formalized through official offering documents and may be subject to jurisdictional and eligibility restrictions.

Research into the implementation of the Dyson sphere on a small scale.
Application of particle research and study technologies.
Advancement of organic-synthetic technologies.

Phase 4 – 2032 - 2042 | Dyson sphere, Study of particles

⚠️ Disclaimer: SpaceJX's content is for informational purposes only and does not constitute an offer to sell or a solicitation to buy any securities. Forward-looking statements are subject to risks and uncertainties. None of the technologies described have regulatory approval.

Invest in the Future with a SAFE
A Simple Agreement for Future Equity (SAFE) allows visionary investors to support our mission today and receive equity in the future when we raise our next funding round.

Support our mission today through a SAFE (Simple Agreement for Future Equity) and receive equity in a future funding round—with a potential 30% conversion benefit when we raise our next Series A.